Despite the steady increase in female participation in sport over the last two decades, comprehensive research on interventions attenuating the influence of female menstrual physiology on performance remains scarce. Studies involving eumenorrheic women often only test in one menstrual phase to limit sex hormone variance, which may restrict the application of these findings to the rest of the menstrual cycle. The impacts of nutrition-based interventions on athletic performance throughout the menstrual cycle have not been fully elucidated. We addressed this gap by conducting a focused critical review of clinical studies that reported athletic outcomes as well as menstrual status for healthy eumenorrheic female participants. In total, 1443 articles were identified, and 23 articles were included. These articles were published between 2011 and 2021, and were retrieved from Google Scholar, Medline, and PubMed. Our literature search revealed that hydration-, micronutrient-, and phytochemical-based interventions can improve athletic performance (measured by aerobic capacity, anaerobic power, and strength performance) or attenuate exercise-induced damage (measured by dehydration biomarkers, muscle soreness, and bone resorption biomarkers). Most performance trials, however, only assessed these interventions in one menstrual phase, limiting the application throughout the entire menstrual cycle. Improvements in athletic performance through nutrition-based interventions may be contingent upon female sex hormone variation in eumenorrheic women.

As wearable technology (WT) has evolved, devices have developed the ability to track a range of physiological variables. These include maximal aerobic capacity (VO2max) and lactate threshold (LT). With WT quickly growing in popularity, independent evaluation of these devices is important to determine the appropriate use-cases for the devices. Therefore, the purpose of this study was to determine the validity of WT in producing estimates of VO2max and LT in athletic populations. METHODS: 21 participants completed laboratory LT and VO2max testing, as well as an outdoor testing session guided by the WT being tested (Garmin fēnix 6® watch and accompanying heart rate monitor). Statistical analysis was completed, using hypothesis testing (ANOVA, t-test), correlation analysis (Pearson’s r, Lin’s Concordance Correlation [CCC]), error analysis (mean absolute percentage error [MAPE]), equivalence testing (TOST test), and bias assessment (Bland–Altman analysis). RESULTS: The Garmin watch was found to have acceptable agreement for VO2max when compared to the 1 min averaged values (MAPE = 6.85%, CCC = 0.7) and for LT and the onset of blood lactate accumulation (OBLA), (MAPE = 7.52%, CCC = 0.79; MAPE = 8.20%, CCC = 0.74, respectively). Therefore, the Garmin fēnix 6® produces accurate measurements of VO2max and LT in athletic populations and can be used to make training decisions among athletes.

Cases of diabetes mellitus have seen a global increase in prevalence, but there are inherent differences in the pathology and management of different types of diabetes. Type 2 and gestational diabetes have the most similar pathophysiology. For that reason, many similar management strategies exist between type 2 and gestational diabetes, including nutrition-based interventions. Diabetes self-management education and medical nutrition therapy have been advanced as cost-effective interventions to manage hyperglycemia. Many of these interventions, however, were designed for type 2 diabetes and adapted for diabetes in gestation. Nutrition-education-based interventions in gestational diabetes have not been fully elucidated. We scrutinized this gap by conducting a scoping review of recently published peer-reviewed studies that evaluated clinical endpoints in cases of gestational diabetes with nutrition-education-based interventions. The search yielded 621 articles, and the 12 articles included were published between 2012 and 2022. The nutrition information varied across the heterogeneous diabetes self-management education, whereas the medical nutrition therapy studies were more consistent. Our literature search revealed similar outcomes across self-management education and medical nutrition therapy interventions implemented during the third trimester of pregnancies with diabetes. These results suggest that both generalized and personalized approaches to nutrition education in gestational diabetes can manage hyperglycemia and offset its adverse consequences.

No abstract

elevated levels of CK at 24h (∆335%) and 48h (∆175%) post the DHR protocol were statistically correlated (p < 0.05) with the following at 24h and 48h: increases in VAS (r = 0.44 and 0.45, respectively), decreases in stride-length (r = -0.57 to -0.43, respectively), and increases in cadence (r = 0.55 to 0.45, respectively). Second, elevated levels of IL-6 at 48h post the DHR (∆16%) were statistically correlated with reductions (∆ -14 to -24%) in MVC at all-time points (r = -0.62 to -0.74). Third, lower levels of the proinflammatory cytokine TNF-a at 48H (∆25%) were statistically correlated with reductions in CMJ at 30min to 48h (∆ -11 to -6%; r = -0.45 to -0.57). CONCLUSION: Biochemical perturbations are moderately to strongly correlated with heightened perception of muscle soreness, alternation in running biomechanics, and reductions in force production and jump height. Accordingly, these subjective, biomechanical and performance outcomes can be carefully used to assess the severity of muscle damage when invasive biochemical measures are unavailable.